TORONTO, Sept. 17, 2018 /CNW/ - 48North Cannabis Corp. ("48North" or the "Company") (TSXV:NRTH), Canada's leading licensed cannabis producer focused on the female health and wellness market, has released its operating and financial results for the fiscal year ended June 30, 2018. The Company's financial statements and related management discussion and analysis for the period are available on the Company's SEDAR profile at www.sedar.com and on the Company's website at www.48nrth.com. All amounts expressed are in Canadian dollars.

"We achieved many important milestones over the past year to position 48North as an innovative and future-focused cannabis company," said Alison Gordon, Chief Executive Officer at 48North. "We continue to watch the cannabis market evolve into what we consider a growing consumer packaged goods industry where we see opportunity to develop brands and cannabis-based products focused on the female health and wellness market."

"Since receiving our cannabis sales license in late June 2018, we began to sell our cannabis to a number of other licensed producers," continued Ms. Gordon. "The craft-like quality and carefully selected cultivars backstop the 48North brand and has resulted in competitive bids for our product. To diversify our revenue and leverage our brand beyond dried cannabis sales, our focus will be on future legalization of extracted products like vape pens, cannabis-infused edibles, cosmetics and skincare."

Operating Highlights for Fiscal 2018

Completed harvesting of initial cultivation in November 2017

Completed $16.1 million brokered private placement financing on January 26, 2018

brokered private placement financing on Common shares began trading on the TSX Venture Exchange on June 11, 2018 under the symbol "NRTH"

under the symbol "NRTH" Received cannabis sales license from Health Canada on June 22, 2018

Strengthened management team with the promotion of Alison Gordon to Chief Executive Officer, and the additions of David Hackett as Chief Financial Officer, Kevin Helfand as Chief Operating Officer and Kirsten Gauthier as Chief Marketing Officer

to Chief Executive Officer, and the additions of as Chief Financial Officer, as Chief Operating Officer and as Chief Marketing Officer Added 14 production personnel to the Kirkland Lake, ON , grow facility

, grow facility Added industry experts to Board of Directors, including William Assini and Anne Darche

Events Subsequent to Year End

Began selling cannabis in the first fiscal quarter of 2019

Received license to extract and produce cannabis oil in September 2018

Launched Latitude, the Company's first lifestyle brand and online storytelling platform to empower and educate women on cannabis use

Selected Financial Information for Fiscal 2018

All amounts are expressed in Canadian dollars



Year Ended June 30, 2018 Year Ended June 30, 2017 Revenue(1) Nil Nil





Net comprehensive loss (12,817,099) (7,178,100) Basic and diluted loss per share (0.217) (0.179) Total assets 25,466,102 17,486,375 Total liabilities 1,439,292 912,937 Cash on hand 12,231,484 3,876,877





(1) During the year ended June 30, 2018, the Company did not generate revenues as its license to sell cannabis was granted on June 22, 2018.

Conference Call

The Company will host a conference call tomorrow, September 18, 2018, to review its fiscal year ended June 30, 2018. The call will be hosted by Alison Gordon, Chief Executive Officer, and David Hackett, Chief Financial Officer, at 8:30 a.m. ET.

Date: Tuesday, September 18, 2018

Time: 8:30 a.m. ET

Dial-in: 647-427-7450 / 1-888-231-8191

Conference ID#: 9691057

A replay of the call will be available until 12:00 midnight ET, September 25, 2018.

Replay dial-in: 416-849-0833 / 1-855-859-2056

Replay ID#: 9691057

About 48North

48North Cannabis Corp. ("48North") is a TSX Venture Exchange listed company whose wholly owned subsidiary DelShen Therapeutics Corp. ("DelShen"), is a licensed producer of medical cannabis in Canada. 48North grows unique genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical company with over 25 years of experience in the research and cultivation of cannabis for medical purposes. Its genetics are grown to exacting standards, ensuring patients can count on receiving the highest-quality cannabis products.

DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations and the facility is located on 800-acres of owned land near Kirkland Lake, Ontario. DelShen's license to produce cannabis was granted on February 28, 2017, and pertains to the facility, a state-of-the-art, closed-box, 40,000-square-foot building.

DISCLAIMER & READER ADVISORY

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The business of the Company is subject to a number of material risks and uncertainties. Please refer to the Filing Statement and other SEDAR filings for further details. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third parties approvals, and licensing and other risks associated with regulated ACMPR entities. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

SOURCE 48North Cannabis Corp.

For further information: Heidi Christensen Brown, 48North Investor Relations, (416) 848-1389, [email protected]; David Hackett, Chief Financial Officer, 48North, (416) 639 5891 ext 304, [email protected]